Alan Knuckman

Analyst Articles

The recovery in the Japanese equity market recovery marked some of the best performance in 2013. The benchmark Nikkei 225 Index (essentially the Dow Jones Industrial Average of Japan) rallied more than 55% — its best showing since the 1970s. The economy of Japan had been mired in what many… Read More

The recovery in the Japanese equity market recovery marked some of the best performance in 2013. The benchmark Nikkei 225 Index (essentially the Dow Jones Industrial Average of Japan) rallied more than 55% — its best showing since the 1970s. The economy of Japan had been mired in what many… Read More

Gold had its first negative year in more than a decade as the bullish bias all but disappeared among investors. It has now experienced a 35%-plus drop from a record high above $1,900 an ounce in 2011. The June lows were tested in the past few weeks, but a bullish… Read More

Gold had its first negative year in more than a decade as the bullish bias all but disappeared among investors. It has now experienced a 35%-plus drop from a record high above $1,900 an ounce in 2011. The June lows were tested in the past few weeks, but a bullish… Read More

The holiday season can bring cheer to retailers that count on it to deliver a large portion of yearly sales. It’s been a good year for the sector so far, with the SPDR S&P Retail ETF (NYSE: XRT) outperforming the broader market with a 40%-plus year-to-date gain. But not all… Read More

The holiday season can bring cheer to retailers that count on it to deliver a large portion of yearly sales. It’s been a good year for the sector so far, with the SPDR S&P Retail ETF (NYSE: XRT) outperforming the broader market with a 40%-plus year-to-date gain. But not all… Read More

Shares of J. C. Penney (NYSE: JCP) bounced from an extreme low of $6.24 on Oct. 22, reclaimed the $8 pivot point, and climbed above $10 in just over a month’s time. Notice how the stock’s slide accelerated in October when $8 was broken on the downside, and also how… Read More

Shares of J. C. Penney (NYSE: JCP) bounced from an extreme low of $6.24 on Oct. 22, reclaimed the $8 pivot point, and climbed above $10 in just over a month’s time. Notice how the stock’s slide accelerated in October when $8 was broken on the downside, and also how… Read More

In a stellar year for most sectors, many health-related stocks have outperformed. iShares US Medical Devices (NYSE: IHI) is up 32% year to date compared to a 25% gain in the S&P 500. And among that fund’s holdings is Boston Scientific (NYSE: BSX), whose stellar run in 2013 has led… Read More

In a stellar year for most sectors, many health-related stocks have outperformed. iShares US Medical Devices (NYSE: IHI) is up 32% year to date compared to a 25% gain in the S&P 500. And among that fund’s holdings is Boston Scientific (NYSE: BSX), whose stellar run in 2013 has led… Read More